Clinical outcomes of patients with unresectable primary liver cancer treated with yttrium-90 radioembolization with an escalated dose
Advances in Radiation Oncology
Open Access Publication
Rights and Permissions
Chin RI, Bommireddy A, Fraum TJ, Ludwig DR, Huang Y, Zoberi JE, Garcia-Ramirez JL, Maughan NM, Chapman W, Korenblat K, Henke LE, Kim H, Badiyan SN. Clinical Outcomes of Patients With Unresectable Primary Liver Cancer Treated With Yttrium-90 Radioembolization With an Escalated Dose. Adv Radiat Oncol. 2022 Mar 21;7(4):100948. doi: 10.1016/j.adro.2022.100948. © 2022 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Chin, Re-I; Bommireddy, Anirudh; Fraum, Tyler J; Ludwig, Daniel R; Huang, Yi; Zoberi, Jacqueline E; Garcia-Ramirez, Jose L; Maughan, Nichole M; Chapman, William; Korenblat, Kevin; Henke, Lauren E; Kim, Hyun; and Badiyan, Shahed N, "Clinical outcomes of patients with unresectable primary liver cancer treated with yttrium-90 radioembolization with an escalated dose." Advances in Radiation Oncology. 7, 4. 100948 (2022).
ICTS (Institute of Clinical and Translational Sciences)
Supplemental material is available for this article at publisher site.